HOME >> MEDICINE >> NEWS
9/11 one year on: Bridging the worlds divisions

This week, THE LANCET'S editorial and an eight-page special report examine the impact of the events of September 11 last year on world politics and public health. The Special Report, replacing the news section for this week's issue, begins in the emergency rooms of New York City and ends at last week's World Summit on Sustainable Development (WSSD) in Johannesburg.

Authors of a study in this week's issue of THE LANCET provide strong evidence that formal counselling after traumatic events is ineffective--and that it could actually do more harm than good.

Traumatic events such as the September 11 2001 attacks have highlighted the issue of psychological support for people who have been traumatised; offers of emotional and practical support to victims are thought to be appropriate and caring human responses. However, conflicting evidence surrounds the effectiveness of single-session psychological debriefing, a commonly used approach to help people who have recently experienced trauma.

Arnold van Emmerik and colleagues from the University of Amsterdam, Netherlands, assessed the value of single-session debriefing after trauma in the subsequent prevention of chronic symptoms of post-traumatic stress disorder (PTSD) and other psychological disorders. They pooled and re-analysed previous studies, some of which involved a specific type of counselling called critical incident stress debriefing (CISD); this typically involves one three-hour, group therapy session for trauma victims. The investigators restricted their analysis to studies where single-session debriefing had been done within one month of the traumatic event, and to studies that involved the use of widely accepted psychological measures to assess behaviour.

Seven studies were reanalysed, which included data about five CISD interventions, three non-CISD interventions, and six controls (ie, no intervention at all). PTSD symptoms improved with Non-CISD interventions and no interventi
'"/>

Contact: Richard Lane
richard.lane@lancet.com
44-207-424-4949
Lancet
5-Sep-2002


Page: 1 2

Related medicine news :

1. Bridging the language barrier
2. Docetaxel versus paclitaxel in breast cancer Results of worlds first head to head trial

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: one year Bridging the worlds divisions

(Date:6/19/2013)... UK (PRWEB) June 19, 2013 Tools4ever, ... is sponsoring today's event, at which it will be ... as well as giving further insight into its leading-edge ... for IT & business professionals specialising in IDM infrastructure ... range of markets including the public sector, banking, finance ...
(Date:6/19/2013)... 2013 Bonita ™ Hair Skin ... for years, to many conditions that range from hair ... wrinkles. Essential Source® has now developed a single serving, ... that is not only stronger than the original Bonita ... vegan community. , Justin Zehrung, Vice President ...
(Date:6/19/2013)... 19, 2013 The Mesothelioma Victims ... Control of the 2500 to 3000 citizens, who will ... mesothelioma this year, about one third will be US ... diagnosed with this asbestos exposure form of cancer, or ... access to the nations most skilled mesothelioma compensation settlement ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 Faith4Kidz is starting ... Faith equals Peace". Faith4Kidz would like help showing support for ... ways that are more positive. Check out the website, ... Faith4Kidz. The logo is red, white and blue stars as ... for independence throughout history as well as the stars we ...
(Date:6/18/2013)... Chicago, IL (PRWEB) June 18, 2013 Exposed ... is helping thousands of acne suffers of all ages finally ... Unlike other acne treatment products, this new acne clearing system ... current acne, and prevent new acne from forming. ... , ExposedSkinCareReview.org believes these products are some of the most ...
Breaking Medicine News(10 mins):Health News:Essential Source ® Improves On Best Selling Bonita ™ Hair Skin and Nail Product 2Health News:Mesothelioma Victims Center Urges US Navy Veterans Diagnosed With Mesothelioma To Call Them For Instant Access To The Nation's Top Asbestos Lawyers-Better Compensation 2Health News:Mesothelioma Victims Center Urges US Navy Veterans Diagnosed With Mesothelioma To Call Them For Instant Access To The Nation's Top Asbestos Lawyers-Better Compensation 3Health News:Faith4Kidz Introduces Patriotic Hats to Benefit the "Grace in Faith Equals Peace" Mission 2Health News:Exposed Skin Care Review Released by ExposedSkinCareReview.org 2Health News:Exposed Skin Care Review Released by ExposedSkinCareReview.org 3
(Date:6/19/2013)... June 19, 2013  It may seem like an odd ... breast cancer. But these were two of the most talked ... Annual Meeting & Expo that just convened in ... this focus by some of the top internal medicine experts ... with new research that can not only save lives, but ...
(Date:6/18/2013)... 19, 2013 , Safinamide ... (PD) patients as add-on to levodopa ... motor symptoms in fluctuating PD patients as add-on ... Pharmaceuticals S.p.A. ("Newron"), a research and development company ... its partner Zambon S.p.A., a pharmaceutical company strongly ...
(Date:6/18/2013)... 18, 2013 Valeant Pharmaceuticals International, Inc. (NYSE: ... announced today that VPII Escrow Corp., a newly formed ... its offer of approximately $3.2 billion aggregate principal amount ... be due in 2021 and in 2023, with final ... to use the net proceeds from the offering, together ...
Breaking Medicine Technology:"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 2"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 3"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 4Safinamide Phase III Study Results Presented at 2013 MDS Meeting 2Safinamide Phase III Study Results Presented at 2013 MDS Meeting 3Safinamide Phase III Study Results Presented at 2013 MDS Meeting 4Safinamide Phase III Study Results Presented at 2013 MDS Meeting 5Safinamide Phase III Study Results Presented at 2013 MDS Meeting 6Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 2Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 3
Cached News: